1 option
Calcium channel blockers and renal disease / [edited by] Nicolas Roberto Robles.
- Format:
- Book
- Series:
- Cerebrovascular Research and Disorders
- Language:
- English
- Subjects (All):
- Kidneys--Diseases--Chemotherapy.
- Kidneys.
- Calcium--Antagonists.
- Calcium.
- Physical Description:
- 1 online resource (195 p.)
- Edition:
- 1st ed.
- Place of Publication:
- Hauppauge, NY : Nova Science Publishers, c2009.
- Language Note:
- English
- Summary:
- The use of calcium antagonists in hypertension & specifically, hypertensive & diabetic kidney disease provides the subject of this book. Scientific research has improved drug designs with better pharmacodynamic profile that allows once daily administration & twenty four hours antihypertensive effects.
- Contents:
- Intro
- CALCIUM CHANNEL BLOCKERSAND RENAL DISEASE
- CALCIUM CHANNEL BLOCKERS AND RENAL DISEASE
- Contents
- Preface
- List of Authors
- Pharmacology of CalciumAntagonists
- Mechanisms of Action
- Differences among Calcium-Antagonists
- Clinical Pharmacology
- Pharmacokinetics
- Pharmacodynamics
- Tolerance
- Sympathetic Activation
- Ankle edema
- Other Untoward Effects
- Therapeutic Uses
- Hypertension
- Angina Pectoris
- Supraventricular Arrhythmias
- Subarachnoid Hemorrhage
- Myocardial Infarction
- Risk of Cancer
- Drug Interactions
- Special Considerations
- Older Patients
- Metabolic Syndrome
- Patients with Congestive Heart Failure
- Overdose of CCBs
- References
- Calcium Antagonists and SystemicHypertension
- Abstract
- Calcium Channel Blockers:The Findings of Clinical Trials
- Calcium Channel Blockers and Target OrganDisease
- 1. Calcium Channel Blockers and Arteriosclerosis
- 2. Use of Calcium Channel Antagonists in Coronary Disease(CHD)
- 3. Effects on Cerebrovascular Disease: Clinical Trials
- 4. Meta-Analysis on Cerebrovascular Outcomes
- Conclusions
- Effects of Calcium Antagonists inRenal Hemodynamics
- 1. Ca2+ Channels and Vasoconstriction
- 1.1. Diversity of Ca2+ Channels
- 1.2. The Traditional Vision: The Role of L-Type Ca2+ Channels
- 1.3. The Emerging Evidences for Other Types of Ca2+ Channels
- 2. The Use of CCBs for BP Control inHypertension
- 2.1. The Principle of Ca2+ Antagonism
- 2.2. The Mechanism of "Ca2+ Antagonism" in Hypertension
- 3. Effects of CCBs on Microcirculation andRenal Hemodynamics
- 3.1. CCBs and Renal Protection
- 3.2. Mechanisms for Beneficial Renal Effects of New CCBs
- 3.2.1. DHP-Insensitive Ca2+ Channels in the Microcirculation andKidneys
- 3.2.2. DHP-Insensitive Ca2+ Channels in the Sympathetic Nerves.
- 3.2.3. New DHPs Cause New Effects on Renal Function
- 3.2.4. Limitations and Pertaining Questions
- Conclusion - Prospects
- The Non-Hemodynamic Effects ofCalcium Channel Blockers on theKidney
- 1. Introduction
- 2. Antioxidant Effects
- 2.1. End-Stage Renal Disease
- 2.2. Diabetes
- 2.3. Effects of Associations
- 3. Effect on the Proliferation of MesangialCells
- 4. Effect on Fibrosis and Apoptosis
- 5. Other Effects
- Summary
- Renoprotective Effect of CalciumAntagonists in SystemicHypertension
- Introduction
- Overview of Relevant Trials Regarding CCBsand Renal Protection in HypertensivePatients
- CCBs and Renal Protection in the Presenceof Preserved Renal Function
- Blood Pressure Control andNephroprotection in Patients withEstablished Chronic Kidney Disease
- Calcium Antagonists and RenalDisease
- Effects Calcium Channel Blockers on RenalHemodynamics
- Renoprotective Effect of CalciumAntagonists in Animals
- Effects on the Progression of Renal Injuryin Humans
- Calcium Antagonists versus Renin-Angiotensin Axis Blocking Drugs
- Calcium Antagonists versus Diuretics
- Comparison between Calcium-Antagonists
- New Calcium Antagonists
- Conclusion
- Renal Ischaemia and CalciumChannel Blockers (CCBs)
- Chronic Renal Ischaemia
- Definition
- Pathogenic Mechanisms
- Epidemiology
- Morphology
- Clinical Presentation
- Calcium Channel Blockers and RID
- Contrast-Induced Nephropathy AND CCBs
- Risk Factors OF CIN
- Prevention of Radiocontrast Nephropathy
- Calcium Antagonist after KidneyTransplantation
- Drug Treatment in Post-TransplantationArterial Hypertension
- Non Dihydropyridinic CalciumAntagonists and Renal Disease.
- Nondihydropiridine Calcium ChannelBlockers vs Other Antihypertensive Agents
- Combination Therapy
- Index.
- Notes:
- Description based upon print version of record.
- Includes bibliographical references and index.
- ISBN:
- 1-61209-867-3
- OCLC:
- 847090008
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.